$NAUT
Nautilus Biotechnology, Inc.
Nasdaq · Technology · Laboratory Analytical Instruments · Seattle, WA
NAUT chart
What traders are saying about $NAUT
Latest postsNautilus Biotechnology, Inc. news
- Nautilus Biotechnology, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Nautilus (NAUT) Q3 2026 Earnings Call Transcript
fool.com ·
- Nautilus Biotechnology Q3 Earnings Call Highlights
marketbeat.com ·
- Nautilus Biotechnology Q3 2026 Earnings Call Transcript
Benzinga ·
- Nautilus Biotechnology Posts $200K in Q3 Revenue, Net Loss Rises to $15.6M
GenomeWeb ·
- Nautilus Biotechnology to receive up to 6 million dollars for ARPA-H-backed protein analysis project
Traders Union ·
- Nautilus Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
marketscreener.com ·
- Nautilus Biotechnology 3Q 2026: Revenue $234K, Net loss ($15.64M), EPS ($0.12) — 10-Q Summary
TradingView ·
- Nautilus Biotechnology earnings beat by $0.02, revenue topped estimates
Investing.com UK ·
- Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 2c
StreetInsider ·
- Nautilus Biotechnology Q3 revenue beats
TradingView ·
- Nautilus Biotechnology Reports $0.2 Million Revenue and $15.6 Million Net Loss
TradingView ·
Nautilus Biotechnology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$59.0M | -$70.8M | -$63.7M | -$57.9M |
| Diluted EPS | $-0.47 | $-0.56 | $-0.51 | $-0.46 |
| Total assets (year end) | $191.1M | $242.7M | $305.6M | $350.1M |
| Cash and equivalents (year end) | $12.4M | $27.6M | $19.4M | $114.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Nautilus Biotechnology, Inc.
- Ticker
- NAUT (Nasdaq)
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Seattle, WA
- Fiscal year end
- December 31
- SEC CIK
- 1808805
- Former names
- ARYA Sciences Acquisition Corp III
Frequently asked questions
What exchange is Nautilus Biotechnology, Inc. listed on?
Nautilus Biotechnology, Inc. trades on the Nasdaq under the ticker symbol NAUT.
What industry is Nautilus Biotechnology, Inc. in?
Nautilus Biotechnology, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.
Where is Nautilus Biotechnology, Inc. headquartered?
Nautilus Biotechnology, Inc.'s business address on file with the SEC is in Seattle, WA.
When does Nautilus Biotechnology, Inc.'s fiscal year end?
Nautilus Biotechnology, Inc.'s fiscal year ends on December 31.